Badr University

buc.edu.eg

Total trials

58

Active

18

Phase 3

4

Total enrollment

3,278

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 13 of 13 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Pioglitazone1
Empagliflozin1
Statin1
Empagliflozin plus Statin1
Pioglitazone plus Atorvastatin1
use of adapalene gel 0.1% and hyaluronic acid at bedtime1
use of adapalene gel 0.1% once daily at bedtime1
Metformin1
Alpha-Lipoic Acid (ALA)+PT1
Omega-3 cap+ PT1
Erythropoietin + Probiotic1
EPO1
Metformin gel Iontophoresis1

Next readouts

  • 2025-10-21
  • 2026-01-01
  • 2026-02-01
  • 2026-03-15
  • 2026-04-15
  • 2026-06-01

Top conditions

  • Alveolar Osteitis2
  • Obesity2
  • Insulin Resistance2
  • Diplegia2
  • Class IV Dental Caries2
  • Hemiplegic Cerebral Palsy2
  • Cancer1
  • Down Syndrome1

Frequently asked questions about Badr University

How many clinical trials does Badr University have on ClinicalTrials.gov?
Badr University is listed as the lead sponsor on 58 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
How many of Badr University's trials are in Phase 3?
4 of Badr University's trials are in Phase 3, spread across 13 active drug programs.
What therapeutic areas does Badr University focus on?
Badr University's most-studied conditions on ClinicalTrials.gov are Alveolar Osteitis, Obesity, Insulin Resistance, Diplegia, Class IV Dental Caries.
When are Badr University's next clinical trial readouts?
Badr University has 6 upcoming primary-completion readouts tracked here; the soonest is “Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris”, expected around 2025-10-21.